@arcportal.org.auThe ARC Portal brings together a trusted national and international network of rare cancer expertise into one accessible gateway. And best of all, it’s free, and easy to use.
More on how to access: https://www.arcportal.org.au/how-to-access-arc-portal
@arcportal.org.auA world first multi indication PBS listing for nivolumab and ipilimumab now covers all immunotherapy sensitive advanced or metastatic cancers, regardless of tumour type.
Read more: https://www.arcportal.org.au/new-pbs-listing-for-immunotherapy-access
@arcportal.org.au📅 Mark your calendars! From clinical symposiums to advocacy forums and scientific meetings, there's a lot happening over the coming months for the rare cancer community, clinicians and researchers alike.
@arcportal.org.auOur new website makes it easier than ever for oncologists to find the information they need about the ARC Portal. Know an oncologist who hasn't heard of us? Share this with them!
@arcportal.org.auARC Portal's Dr Betty Zhang attended CanForum26 at Parliament House last week. Thank you to Rare Cancers Australia for bringing together patients, clinicians, advocates and policymakers to tackle rare cancers together.
